knowledge -WSS

knowledge

author：knowledge 2025-09-10 02:23:07 - browse：9397

Under the Affordable Care Act, health insurers are required to cover all costs associated with preventive care — including PrEP, or pre-exposure prophylactic treatment for HIV. But now all preventive care coverage is under threat, thanks to a lawsuit filed by employers who believe they shouldn’t be required to pay for care that violates their religious beliefs.

While coverage for PrEP access is largely unchanged as the court case makes its way through the legal system, Richard Hughes IV, a partner with the law firm Epstein Becker Green, says that protecting the status quo isn’t enough. For instance, currently you have to jump through extra hoops to get long-acting injectable PrEP covered by insurance.

But Hughes has a better idea for how to not only protect but also expand access to PrEP.

On this episode of the “First Opinion Podcast,” I spoke to Hughes about his proposal, why access to PrEP has never been what it should be, the Supreme Court’s current approach to health care, and more.

“If a provider has a bad experience with a previous patient experiencing non-coverage, they might say to the next patient, ‘Well, I’m not sure this is going to be covered.’ And that can be really discouraging,” Hughes said. “What we really need to create that clarity for patients is for this law to be upheld, for the recommendations to be clear, and for providers to have the assurance that they will be covered by payers.”

Our conversation was based on his recent First Opinion op-ed, “How to protect PrEP coverage, no matter what happens in Braidwood v. Becerra.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — First Opinion authors to feature on the podcast, kudos, or darts — email us at [email protected] and please put “podcast” in the subject line.

Previous article： Activists slam private health insurers over coverage restrictions
Next article： CDC's new outbreak response network to include Northeastern

leisure time

WSS

Biotech stock slump in 2023: awaiting the turnaround

Biotech stock slump in 2023: awaiting the turnaround

CDC's new outbreak response network to include Northeastern

Wildfire pollution widens asthma inequities on Long Island

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

The high personal cost of affirmative action for Black doctors

explore

knowledge

focus

As demand for Covid shots wanes, Moderna seeks its next success

Lawsuit alleges UnitedHealth Group unit illegally denied claims

BioMarin wins approval for gene therapy to treat hemophilia A

Mitch McConnell episode has important public health takeaway

At least 13 dead in Texas as scorching temps continue

Lasker Awards 2023: Winners in biomedical research

Guidelines to prevent youth baseball injuries need more muscle

STAT Virtual Event: Putting AI to the Test

Guidelines to prevent youth baseball injuries need more muscle

Intarcia’s device

leisure time

Scientists inch closer to single

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

CDC advisers recommend seasonal use of Pfizer RSV shot

Wildfire pollution widens asthma inequities on Long Island

What to expect as Trump is arraigned on his Jan 6. indictment

EQRx, failed developer of low

focus

leisure time

leisure time

hotspot